Zobrazeno 1 - 10
of 245
pro vyhledávání: '"C. Van Poznak"'
Autor:
J.E. Brown, S.L. Wood, C. Confavreux, M. Abe, K. Weilbaecher, P. Hadji, R.W. Johnson, J.A. Rhoades, C.M. Edwards, P.I. Croucher, P. Juarez, S. El Badri, G. Ariaspinilla, S. D'Oronzo, T.A. Guise, C. Van Poznak
Publikováno v:
Journal of Bone Oncology, Vol 29, Iss , Pp 100375- (2021)
Optimum management of patients with cancer during the COVID-19 pandemic has proved extremely challenging. Patients, clinicians and hospital authorities have had to balance the risks to patients of attending hospital, many of whom are especially vulne
Externí odkaz:
https://doaj.org/article/30d060a58a1744a6a9c195bb81b941dc
Autor:
H.S. Rugo, K. Drumea, S.C. Lee, M. Campone, C. Van Poznak, P. Neven, E. Vega Alonso, B. Naume, J.M. Siegel, R. Li, D. Uema, V.J. Wagner, R.E. Coleman
Publikováno v:
Annals of Oncology. 33:S211-S212
Autor:
Stéphane Oudard, Matti Aapro, Peyman Hadji, Øyvind S. Bruland, E. Chow, E. Terpos, Jean-Jacques Body, Patrick Flamen, Daniele Santini, Robert E. Coleman, Andreas Kurth, C. Van Poznak, Karin Jordan
Publikováno v:
Annals of oncology
SCOPUS: ar.j
info:eu-repo/semantics/published
info:eu-repo/semantics/published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b4855162922c698eeb1ce6208f1be40
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313653
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313653
Autor:
Donald B. Kimmel, E.J. Castillo, José Aguirre, J.M. Jiron, N. Bhattacharyya, C. Van Poznak, Jonathan G. Messer, J.L. Mendieta Calle
Publikováno v:
Bone
Objective Investigate role of dose/duration of zoledronic acid (ZOL), a powerful anti-resorptive (pAR), on prevalence of medication-related osteonecrosis of the jaw (MRONJ) in rice rats (Oryzomys palustris), a species with natural susceptibility to f
Autor:
E van Leeuwen-Stok, G Werutsky, K Aalders, Sharon H. Giordano, Kathryn J. Ruddy, Nizet H. Dijkstra, C. Poncet, Corneel Coens, Fatima Cardoso, C. P. Schroder, D Morgenstern, Antonio C. Wolff, C. Van Poznak, Barbro Linderholm, Henry L. Gomez, Konstantinos Tryfonidis, Vesna Bjelic-Radisic
Publikováno v:
Cancer Research. 78:P5-23
Introduction: Male BC is a rare disease (dx) for which management is extrapolated from trials in female BC. Comprehensive prospective data about QoL in men with BC could inform treatment. The international Male BC Consortium conducted a prospective r
Autor:
Awg van der Velden, Jms Bartlett, I Bozovic-Spasojevic, MM Vleugel, Nicola S. Russell, Isabel T. Rubio, S Hilsenbeck, Sharon H. Giordano, C. Poncet, Miguel Henriques Abreu, A Wolff, Chm van Deurzen, C. Van Poznak, Barbro Linderholm, Larissa A. Korde, David Cameron, Idm den Hoed, Carolien P. Schröder, N Dijkstra, KJ Ruddy, Aafke H. Honkoop, D Morganstern, Jwm Martens, Fatima Cardoso, K Aalders, Oliver Bogler, Tineke J. Smilde, T Goulioti, M van 't Riet, Konstantinos Tryfonidis, E van Leeuwen-Stok
Publikováno v:
Cancer Research. 78:P5-23
BACKGROUND: Through the International Male Breast Cancer Program, a prospective registry for male BC was created with the goals of evaluating 1) the clinical and biological features of this disease and 2) assessing feasibility of a prospective therap
Autor:
Pankaj Vats, Monika L. Burness, Arul M. Chinnaiyan, Erin F. Cobain, Robert J. Lonigro, Chandan Kumar-Sinha, Anne F. Schott, Aki Morikawa, Daniel F. Hayes, Robinson, Erica Rabban, C. Van Poznak, Max S. Wicha, Y-M Wu, Jeffrey B. Smerage, Jennifer J. Griggs
Publikováno v:
Cancer Research. 78:P2-09
Background: Immune checkpoint blockade (ICB) is effective in the treatment of various malignancies. Thus far, however, results in breast cancer have been mixed. Elevated tumor mutational load, and subsequent increased likelihood of forming immunogeni
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Abe, Stella D'Oronzo, T.A. Guise, Steven L. Wood, S. El Badri, J.A. Rhoades, Janet E. Brown, Peter I. Croucher, C. Van Poznak, Peyman Hadji, Rachelle W. Johnson, P. Juarez, Cyrille B. Confavreux, C.M. Edwards, G. Ariaspinilla, Katherine N. Weilbaecher
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 29, Iss, Pp 100375-(2021)
Journal of Bone Oncology, Vol 29, Iss, Pp 100375-(2021)
Optimum management of patients with cancer during the COVID-19 pandemic has proved extremely challenging. Patients, clinicians and hospital authorities have had to balance the risks to patients of attending hospital, many of whom are especially vulne
Autor:
S Hwang, Meredith M. Regan, Ta King, Beth Overmoyer, Tufia C. Haddad, Kornelia Polyak, Jane E. Brock, Vered Stearns, C. Van Poznak, EP Winer
Publikováno v:
Cancer Research. 78:OT3-05
Background: Stage III triple negative(TN) inflammatory breast cancer(IBC) is associated with a poor prognosis evidenced by a 15 month(mo) median disease free survival(DFS) and overall survival(OS) of 34 mo. The substantial incidence of developing dis